nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—Haematoma—Sorafenib—liver cancer	0.0117	0.0351	CcSEcCtD
Treprostinil—Cardiac failure congestive—Sorafenib—liver cancer	0.00588	0.0177	CcSEcCtD
Treprostinil—Cardiac failure—Sorafenib—liver cancer	0.00547	0.0164	CcSEcCtD
Treprostinil—Pain in extremity—Sorafenib—liver cancer	0.00533	0.016	CcSEcCtD
Treprostinil—Dehydration—Sorafenib—liver cancer	0.00496	0.0149	CcSEcCtD
Treprostinil—Hypokalaemia—Sorafenib—liver cancer	0.00485	0.0146	CcSEcCtD
Treprostinil—Abdominal discomfort—Sorafenib—liver cancer	0.00442	0.0133	CcSEcCtD
Treprostinil—Pneumonia—Sorafenib—liver cancer	0.00413	0.0124	CcSEcCtD
Treprostinil—Epistaxis—Sorafenib—liver cancer	0.00388	0.0116	CcSEcCtD
Treprostinil—Haemoglobin—Sorafenib—liver cancer	0.00371	0.0111	CcSEcCtD
Treprostinil—Haemorrhage—Sorafenib—liver cancer	0.00369	0.0111	CcSEcCtD
Treprostinil—Haemoptysis—Epirubicin—liver cancer	0.00367	0.011	CcSEcCtD
Treprostinil—Flushing—Sorafenib—liver cancer	0.00342	0.0103	CcSEcCtD
Treprostinil—Haemoptysis—Doxorubicin—liver cancer	0.0034	0.0102	CcSEcCtD
Treprostinil—Erythema—Sorafenib—liver cancer	0.00321	0.00965	CcSEcCtD
Treprostinil—Muscle spasms—Sorafenib—liver cancer	0.00309	0.00927	CcSEcCtD
Treprostinil—Viral infection—Epirubicin—liver cancer	0.00301	0.00903	CcSEcCtD
Treprostinil—Rectal haemorrhage—Epirubicin—liver cancer	0.00301	0.00903	CcSEcCtD
Treprostinil—Cellulitis—Epirubicin—liver cancer	0.00299	0.00897	CcSEcCtD
Treprostinil—Anaemia—Sorafenib—liver cancer	0.00297	0.00892	CcSEcCtD
Treprostinil—Angioedema—Sorafenib—liver cancer	0.00294	0.00881	CcSEcCtD
Treprostinil—Syncope—Sorafenib—liver cancer	0.00288	0.00865	CcSEcCtD
Treprostinil—Bone pain—Epirubicin—liver cancer	0.00284	0.00851	CcSEcCtD
Treprostinil—Loss of consciousness—Sorafenib—liver cancer	0.00282	0.00848	CcSEcCtD
Treprostinil—Cough—Sorafenib—liver cancer	0.0028	0.00842	CcSEcCtD
Treprostinil—Rectal haemorrhage—Doxorubicin—liver cancer	0.00278	0.00835	CcSEcCtD
Treprostinil—Viral infection—Doxorubicin—liver cancer	0.00278	0.00835	CcSEcCtD
Treprostinil—Cellulitis—Doxorubicin—liver cancer	0.00276	0.0083	CcSEcCtD
Treprostinil—Neck pain—Epirubicin—liver cancer	0.00275	0.00825	CcSEcCtD
Treprostinil—Arthralgia—Sorafenib—liver cancer	0.00274	0.00821	CcSEcCtD
Treprostinil—Myalgia—Sorafenib—liver cancer	0.00274	0.00821	CcSEcCtD
Treprostinil—Pulmonary embolism—Epirubicin—liver cancer	0.00272	0.00816	CcSEcCtD
Treprostinil—Melaena—Epirubicin—liver cancer	0.00265	0.00797	CcSEcCtD
Treprostinil—Bone pain—Doxorubicin—liver cancer	0.00262	0.00788	CcSEcCtD
Treprostinil—Infection—Sorafenib—liver cancer	0.0026	0.00782	CcSEcCtD
Treprostinil—Shock—Sorafenib—liver cancer	0.00258	0.00775	CcSEcCtD
Treprostinil—Thrombocytopenia—Sorafenib—liver cancer	0.00257	0.00771	CcSEcCtD
Treprostinil—Neck pain—Doxorubicin—liver cancer	0.00254	0.00764	CcSEcCtD
Treprostinil—Pulmonary embolism—Doxorubicin—liver cancer	0.00251	0.00755	CcSEcCtD
Treprostinil—Anorexia—Sorafenib—liver cancer	0.0025	0.0075	CcSEcCtD
Treprostinil—Cramps of lower extremities—Epirubicin—liver cancer	0.00249	0.00749	CcSEcCtD
Treprostinil—Ecchymosis—Epirubicin—liver cancer	0.00246	0.00737	CcSEcCtD
Treprostinil—Melaena—Doxorubicin—liver cancer	0.00245	0.00737	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00239	0.00717	CcSEcCtD
Treprostinil—Sepsis—Epirubicin—liver cancer	0.00236	0.00708	CcSEcCtD
Treprostinil—Dyspnoea—Sorafenib—liver cancer	0.00234	0.00702	CcSEcCtD
Treprostinil—Cramps of lower extremities—Doxorubicin—liver cancer	0.00231	0.00693	CcSEcCtD
Treprostinil—Dyspepsia—Sorafenib—liver cancer	0.00231	0.00693	CcSEcCtD
Treprostinil—Decreased appetite—Sorafenib—liver cancer	0.00228	0.00684	CcSEcCtD
Treprostinil—Thrombophlebitis—Epirubicin—liver cancer	0.00228	0.00684	CcSEcCtD
Treprostinil—Ecchymosis—Doxorubicin—liver cancer	0.00227	0.00682	CcSEcCtD
Treprostinil—Fatigue—Sorafenib—liver cancer	0.00226	0.00679	CcSEcCtD
Treprostinil—Pain—Sorafenib—liver cancer	0.00224	0.00673	CcSEcCtD
Treprostinil—Sepsis—Doxorubicin—liver cancer	0.00218	0.00655	CcSEcCtD
Treprostinil—Cardiac failure congestive—Epirubicin—liver cancer	0.00217	0.00653	CcSEcCtD
Treprostinil—Gastrointestinal pain—Sorafenib—liver cancer	0.00214	0.00644	CcSEcCtD
Treprostinil—Thrombophlebitis—Doxorubicin—liver cancer	0.00211	0.00633	CcSEcCtD
Treprostinil—Body temperature increased—Sorafenib—liver cancer	0.00207	0.00622	CcSEcCtD
Treprostinil—Abdominal pain—Sorafenib—liver cancer	0.00207	0.00622	CcSEcCtD
Treprostinil—Cardiac failure—Epirubicin—liver cancer	0.00202	0.00607	CcSEcCtD
Treprostinil—Cardiac failure congestive—Doxorubicin—liver cancer	0.00201	0.00604	CcSEcCtD
Treprostinil—Pain in extremity—Epirubicin—liver cancer	0.00197	0.00592	CcSEcCtD
Treprostinil—Asthenia—Sorafenib—liver cancer	0.00188	0.00565	CcSEcCtD
Treprostinil—Cardiac failure—Doxorubicin—liver cancer	0.00187	0.00561	CcSEcCtD
Treprostinil—Pruritus—Sorafenib—liver cancer	0.00185	0.00557	CcSEcCtD
Treprostinil—Dehydration—Epirubicin—liver cancer	0.00183	0.00551	CcSEcCtD
Treprostinil—Pain in extremity—Doxorubicin—liver cancer	0.00182	0.00548	CcSEcCtD
Treprostinil—Hypokalaemia—Epirubicin—liver cancer	0.00179	0.00539	CcSEcCtD
Treprostinil—Diarrhoea—Sorafenib—liver cancer	0.00179	0.00539	CcSEcCtD
Treprostinil—Dizziness—Sorafenib—liver cancer	0.00173	0.00521	CcSEcCtD
Treprostinil—Influenza—Epirubicin—liver cancer	0.0017	0.00512	CcSEcCtD
Treprostinil—Dehydration—Doxorubicin—liver cancer	0.0017	0.00509	CcSEcCtD
Treprostinil—Vomiting—Sorafenib—liver cancer	0.00167	0.00501	CcSEcCtD
Treprostinil—Hypokalaemia—Doxorubicin—liver cancer	0.00166	0.00498	CcSEcCtD
Treprostinil—Rash—Sorafenib—liver cancer	0.00165	0.00496	CcSEcCtD
Treprostinil—Dermatitis—Sorafenib—liver cancer	0.00165	0.00496	CcSEcCtD
Treprostinil—Headache—Sorafenib—liver cancer	0.00164	0.00493	CcSEcCtD
Treprostinil—Bronchitis—Epirubicin—liver cancer	0.00164	0.00492	CcSEcCtD
Treprostinil—Influenza—Doxorubicin—liver cancer	0.00158	0.00473	CcSEcCtD
Treprostinil—Nausea—Sorafenib—liver cancer	0.00156	0.00468	CcSEcCtD
Treprostinil—Pneumonia—Epirubicin—liver cancer	0.00153	0.00459	CcSEcCtD
Treprostinil—Bronchitis—Doxorubicin—liver cancer	0.00152	0.00455	CcSEcCtD
Treprostinil—Urinary tract infection—Epirubicin—liver cancer	0.00148	0.00443	CcSEcCtD
Treprostinil—Haematuria—Epirubicin—liver cancer	0.00145	0.00435	CcSEcCtD
Treprostinil—Epistaxis—Epirubicin—liver cancer	0.00143	0.0043	CcSEcCtD
Treprostinil—Sinusitis—Epirubicin—liver cancer	0.00143	0.00428	CcSEcCtD
Treprostinil—Pneumonia—Doxorubicin—liver cancer	0.00141	0.00425	CcSEcCtD
Treprostinil—Bradycardia—Epirubicin—liver cancer	0.00139	0.00417	CcSEcCtD
Treprostinil—Haemoglobin—Epirubicin—liver cancer	0.00137	0.00412	CcSEcCtD
Treprostinil—Rhinitis—Epirubicin—liver cancer	0.00137	0.00411	CcSEcCtD
Treprostinil—Urinary tract infection—Doxorubicin—liver cancer	0.00137	0.0041	CcSEcCtD
Treprostinil—Haemorrhage—Epirubicin—liver cancer	0.00136	0.0041	CcSEcCtD
Treprostinil—Pharyngitis—Epirubicin—liver cancer	0.00135	0.00406	CcSEcCtD
Treprostinil—Oedema peripheral—Epirubicin—liver cancer	0.00134	0.00403	CcSEcCtD
Treprostinil—Haematuria—Doxorubicin—liver cancer	0.00134	0.00402	CcSEcCtD
Treprostinil—Epistaxis—Doxorubicin—liver cancer	0.00133	0.00398	CcSEcCtD
Treprostinil—Sinusitis—Doxorubicin—liver cancer	0.00132	0.00396	CcSEcCtD
Treprostinil—Bradycardia—Doxorubicin—liver cancer	0.00128	0.00386	CcSEcCtD
Treprostinil—Haemoglobin—Doxorubicin—liver cancer	0.00127	0.00381	CcSEcCtD
Treprostinil—Flushing—Epirubicin—liver cancer	0.00127	0.0038	CcSEcCtD
Treprostinil—Rhinitis—Doxorubicin—liver cancer	0.00127	0.0038	CcSEcCtD
Treprostinil—Haemorrhage—Doxorubicin—liver cancer	0.00126	0.00379	CcSEcCtD
Treprostinil—Pharyngitis—Doxorubicin—liver cancer	0.00125	0.00376	CcSEcCtD
Treprostinil—Oedema peripheral—Doxorubicin—liver cancer	0.00124	0.00373	CcSEcCtD
Treprostinil—Erythema—Epirubicin—liver cancer	0.00119	0.00356	CcSEcCtD
Treprostinil—Flushing—Doxorubicin—liver cancer	0.00117	0.00352	CcSEcCtD
Treprostinil—Tension—Epirubicin—liver cancer	0.00117	0.0035	CcSEcCtD
Treprostinil—Nervousness—Epirubicin—liver cancer	0.00115	0.00346	CcSEcCtD
Treprostinil—Back pain—Epirubicin—liver cancer	0.00115	0.00345	CcSEcCtD
Treprostinil—Muscle spasms—Epirubicin—liver cancer	0.00114	0.00343	CcSEcCtD
Treprostinil—Ill-defined disorder—Epirubicin—liver cancer	0.0011	0.00331	CcSEcCtD
Treprostinil—Erythema—Doxorubicin—liver cancer	0.0011	0.0033	CcSEcCtD
Treprostinil—Anaemia—Epirubicin—liver cancer	0.0011	0.00329	CcSEcCtD
Treprostinil—Tension—Doxorubicin—liver cancer	0.00108	0.00324	CcSEcCtD
Treprostinil—Malaise—Epirubicin—liver cancer	0.00107	0.00321	CcSEcCtD
Treprostinil—Nervousness—Doxorubicin—liver cancer	0.00107	0.0032	CcSEcCtD
Treprostinil—Syncope—Epirubicin—liver cancer	0.00106	0.0032	CcSEcCtD
Treprostinil—Back pain—Doxorubicin—liver cancer	0.00106	0.00319	CcSEcCtD
Treprostinil—Muscle spasms—Doxorubicin—liver cancer	0.00106	0.00317	CcSEcCtD
Treprostinil—Palpitations—Epirubicin—liver cancer	0.00105	0.00315	CcSEcCtD
Treprostinil—Loss of consciousness—Epirubicin—liver cancer	0.00104	0.00313	CcSEcCtD
Treprostinil—Cough—Epirubicin—liver cancer	0.00104	0.00311	CcSEcCtD
Treprostinil—Ill-defined disorder—Doxorubicin—liver cancer	0.00102	0.00306	CcSEcCtD
Treprostinil—Anaemia—Doxorubicin—liver cancer	0.00102	0.00305	CcSEcCtD
Treprostinil—Myalgia—Epirubicin—liver cancer	0.00101	0.00304	CcSEcCtD
Treprostinil—Arthralgia—Epirubicin—liver cancer	0.00101	0.00304	CcSEcCtD
Treprostinil—Chest pain—Epirubicin—liver cancer	0.00101	0.00304	CcSEcCtD
Treprostinil—Anxiety—Epirubicin—liver cancer	0.00101	0.00302	CcSEcCtD
Treprostinil—Discomfort—Epirubicin—liver cancer	0.000999	0.003	CcSEcCtD
Treprostinil—Malaise—Doxorubicin—liver cancer	0.000991	0.00297	CcSEcCtD
Treprostinil—Syncope—Doxorubicin—liver cancer	0.000985	0.00296	CcSEcCtD
Treprostinil—Palpitations—Doxorubicin—liver cancer	0.000971	0.00291	CcSEcCtD
Treprostinil—Oedema—Epirubicin—liver cancer	0.000969	0.00291	CcSEcCtD
Treprostinil—Loss of consciousness—Doxorubicin—liver cancer	0.000966	0.0029	CcSEcCtD
Treprostinil—Infection—Epirubicin—liver cancer	0.000963	0.00289	CcSEcCtD
Treprostinil—Cough—Doxorubicin—liver cancer	0.000959	0.00288	CcSEcCtD
Treprostinil—Shock—Epirubicin—liver cancer	0.000953	0.00286	CcSEcCtD
Treprostinil—Thrombocytopenia—Epirubicin—liver cancer	0.000949	0.00285	CcSEcCtD
Treprostinil—Tachycardia—Epirubicin—liver cancer	0.000946	0.00284	CcSEcCtD
Treprostinil—Chest pain—Doxorubicin—liver cancer	0.000935	0.00281	CcSEcCtD
Treprostinil—Myalgia—Doxorubicin—liver cancer	0.000935	0.00281	CcSEcCtD
Treprostinil—Arthralgia—Doxorubicin—liver cancer	0.000935	0.00281	CcSEcCtD
Treprostinil—Anxiety—Doxorubicin—liver cancer	0.000932	0.0028	CcSEcCtD
Treprostinil—Discomfort—Doxorubicin—liver cancer	0.000924	0.00277	CcSEcCtD
Treprostinil—Anorexia—Epirubicin—liver cancer	0.000924	0.00277	CcSEcCtD
Treprostinil—Hypotension—Epirubicin—liver cancer	0.000905	0.00272	CcSEcCtD
Treprostinil—Oedema—Doxorubicin—liver cancer	0.000897	0.00269	CcSEcCtD
Treprostinil—Infection—Doxorubicin—liver cancer	0.000891	0.00267	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000883	0.00265	CcSEcCtD
Treprostinil—Shock—Doxorubicin—liver cancer	0.000882	0.00265	CcSEcCtD
Treprostinil—Thrombocytopenia—Doxorubicin—liver cancer	0.000878	0.00264	CcSEcCtD
Treprostinil—Insomnia—Epirubicin—liver cancer	0.000876	0.00263	CcSEcCtD
Treprostinil—Tachycardia—Doxorubicin—liver cancer	0.000875	0.00263	CcSEcCtD
Treprostinil—Paraesthesia—Epirubicin—liver cancer	0.00087	0.00261	CcSEcCtD
Treprostinil—Dyspnoea—Epirubicin—liver cancer	0.000864	0.00259	CcSEcCtD
Treprostinil—Anorexia—Doxorubicin—liver cancer	0.000855	0.00257	CcSEcCtD
Treprostinil—Dyspepsia—Epirubicin—liver cancer	0.000853	0.00256	CcSEcCtD
Treprostinil—Decreased appetite—Epirubicin—liver cancer	0.000842	0.00253	CcSEcCtD
Treprostinil—Hypotension—Doxorubicin—liver cancer	0.000838	0.00252	CcSEcCtD
Treprostinil—Fatigue—Epirubicin—liver cancer	0.000835	0.00251	CcSEcCtD
Treprostinil—Pain—Epirubicin—liver cancer	0.000829	0.00249	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000817	0.00245	CcSEcCtD
Treprostinil—Insomnia—Doxorubicin—liver cancer	0.000811	0.00243	CcSEcCtD
Treprostinil—Paraesthesia—Doxorubicin—liver cancer	0.000805	0.00242	CcSEcCtD
Treprostinil—Dyspnoea—Doxorubicin—liver cancer	0.000799	0.0024	CcSEcCtD
Treprostinil—Feeling abnormal—Epirubicin—liver cancer	0.000798	0.0024	CcSEcCtD
Treprostinil—Gastrointestinal pain—Epirubicin—liver cancer	0.000792	0.00238	CcSEcCtD
Treprostinil—Dyspepsia—Doxorubicin—liver cancer	0.000789	0.00237	CcSEcCtD
Treprostinil—Decreased appetite—Doxorubicin—liver cancer	0.000779	0.00234	CcSEcCtD
Treprostinil—Fatigue—Doxorubicin—liver cancer	0.000773	0.00232	CcSEcCtD
Treprostinil—Pain—Doxorubicin—liver cancer	0.000767	0.0023	CcSEcCtD
Treprostinil—Abdominal pain—Epirubicin—liver cancer	0.000766	0.0023	CcSEcCtD
Treprostinil—Body temperature increased—Epirubicin—liver cancer	0.000766	0.0023	CcSEcCtD
Treprostinil—Feeling abnormal—Doxorubicin—liver cancer	0.000739	0.00222	CcSEcCtD
Treprostinil—Gastrointestinal pain—Doxorubicin—liver cancer	0.000733	0.0022	CcSEcCtD
Treprostinil—Abdominal pain—Doxorubicin—liver cancer	0.000709	0.00213	CcSEcCtD
Treprostinil—Body temperature increased—Doxorubicin—liver cancer	0.000709	0.00213	CcSEcCtD
Treprostinil—Asthenia—Epirubicin—liver cancer	0.000695	0.00209	CcSEcCtD
Treprostinil—Pruritus—Epirubicin—liver cancer	0.000686	0.00206	CcSEcCtD
Treprostinil—Diarrhoea—Epirubicin—liver cancer	0.000663	0.00199	CcSEcCtD
Treprostinil—Asthenia—Doxorubicin—liver cancer	0.000643	0.00193	CcSEcCtD
Treprostinil—Dizziness—Epirubicin—liver cancer	0.000641	0.00192	CcSEcCtD
Treprostinil—Pruritus—Doxorubicin—liver cancer	0.000634	0.0019	CcSEcCtD
Treprostinil—Vomiting—Epirubicin—liver cancer	0.000616	0.00185	CcSEcCtD
Treprostinil—Diarrhoea—Doxorubicin—liver cancer	0.000613	0.00184	CcSEcCtD
Treprostinil—Rash—Epirubicin—liver cancer	0.000611	0.00183	CcSEcCtD
Treprostinil—Dermatitis—Epirubicin—liver cancer	0.00061	0.00183	CcSEcCtD
Treprostinil—Headache—Epirubicin—liver cancer	0.000607	0.00182	CcSEcCtD
Treprostinil—Dizziness—Doxorubicin—liver cancer	0.000593	0.00178	CcSEcCtD
Treprostinil—Nausea—Epirubicin—liver cancer	0.000576	0.00173	CcSEcCtD
Treprostinil—Vomiting—Doxorubicin—liver cancer	0.00057	0.00171	CcSEcCtD
Treprostinil—Rash—Doxorubicin—liver cancer	0.000565	0.0017	CcSEcCtD
Treprostinil—Dermatitis—Doxorubicin—liver cancer	0.000565	0.0017	CcSEcCtD
Treprostinil—Headache—Doxorubicin—liver cancer	0.000562	0.00169	CcSEcCtD
Treprostinil—Nausea—Doxorubicin—liver cancer	0.000533	0.0016	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—F2—liver cancer	0.000493	0.000739	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—SERPINE1—liver cancer	0.000488	0.000731	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PRKCE—liver cancer	0.000488	0.000731	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TRIO—liver cancer	0.000474	0.00071	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PIK3CG—liver cancer	0.000472	0.000707	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000472	0.000707	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	0.000464	0.000696	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—HPGDS—liver cancer	0.000458	0.000686	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FST—liver cancer	0.000457	0.000685	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000455	0.000682	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR4—liver cancer	0.000454	0.000681	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PIK3CD—liver cancer	0.000451	0.000676	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PRKCE—liver cancer	0.000449	0.000673	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SERPINE1—liver cancer	0.000446	0.000668	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ALB—liver cancer	0.000445	0.000667	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PRKCE—liver cancer	0.000443	0.000664	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—CYP2E1—liver cancer	0.000439	0.000658	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TRIO—liver cancer	0.000436	0.000654	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP2E1—liver cancer	0.000433	0.000649	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CSF2—liver cancer	0.000431	0.000647	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR4—liver cancer	0.000418	0.000627	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PIK3CD—liver cancer	0.000415	0.000622	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000415	0.000621	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—SERPINE1—liver cancer	0.00041	0.000615	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ALB—liver cancer	0.000409	0.000614	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000409	0.000614	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PSMA4—liver cancer	0.000408	0.000612	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PSMD10—liver cancer	0.000408	0.000612	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PRKCE—liver cancer	0.000408	0.000611	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—GGT1—liver cancer	0.000403	0.000604	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—RAF1—liver cancer	0.000402	0.000603	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CSF2—liver cancer	0.000397	0.000595	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GOT2—liver cancer	0.000397	0.000595	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PIK3CB—liver cancer	0.000393	0.000589	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CSF2—liver cancer	0.000392	0.000587	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—AKT1—liver cancer	0.000379	0.000569	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP2E1—liver cancer	0.000373	0.000559	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—RAF1—liver cancer	0.00037	0.000555	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—GSTP1—liver cancer	0.000362	0.000543	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PIK3CB—liver cancer	0.000361	0.000542	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000361	0.000542	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IL2—liver cancer	0.000361	0.000541	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CSF2—liver cancer	0.00036	0.000541	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADAM17—liver cancer	0.000359	0.000538	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	0.000357	0.000535	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—H2AFX—liver cancer	0.000354	0.000531	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYCS—liver cancer	0.000349	0.000523	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GGT1—liver cancer	0.000343	0.000514	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GOT1—liver cancer	0.000343	0.000514	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—F2—liver cancer	0.000338	0.000508	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PSMD10—liver cancer	0.000338	0.000506	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PSMA4—liver cancer	0.000338	0.000506	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—GSTM1—liver cancer	0.000333	0.000499	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IL2—liver cancer	0.000332	0.000498	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADAM17—liver cancer	0.00033	0.000496	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	0.000328	0.000492	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CG—liver cancer	0.000324	0.000486	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000321	0.000481	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PPARA—liver cancer	0.000315	0.000473	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—CYP1A1—liver cancer	0.000315	0.000473	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—F2—liver cancer	0.000312	0.000467	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	0.000311	0.000466	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PSMA4—liver cancer	0.000311	0.000466	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PSMD10—liver cancer	0.000311	0.000466	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000309	0.000464	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—MYC—liver cancer	0.000309	0.000463	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTP1—liver cancer	0.000308	0.000461	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—F2—liver cancer	0.000307	0.000461	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—VEGFA—liver cancer	0.000307	0.00046	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—HMOX1—liver cancer	0.000304	0.000455	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CG—liver cancer	0.000298	0.000447	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CG—liver cancer	0.000294	0.000441	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MAPK14—liver cancer	0.000291	0.000437	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—ESR1—liver cancer	0.000286	0.000428	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CD—liver cancer	0.000285	0.000427	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—F2—liver cancer	0.000283	0.000424	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTM1—liver cancer	0.000283	0.000424	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—liver cancer	0.000282	0.000423	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TGFB1—liver cancer	0.000281	0.000422	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CG—liver cancer	0.000271	0.000406	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP1A1—liver cancer	0.000268	0.000402	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CD—liver cancer	0.000262	0.000393	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PRKCE—liver cancer	0.000262	0.000392	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PPARG—liver cancer	0.000261	0.000391	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—KRAS—liver cancer	0.000261	0.000391	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TGFB1—liver cancer	0.000259	0.000388	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CD—liver cancer	0.000259	0.000388	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—MTHFR—liver cancer	0.00025	0.000375	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CB—liver cancer	0.000248	0.000372	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF2—liver cancer	0.000248	0.000372	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARA—liver cancer	0.000245	0.000368	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PRKCE—liver cancer	0.000241	0.000361	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—KRAS—liver cancer	0.00024	0.00036	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PIK3CA—liver cancer	0.000239	0.000359	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CD—liver cancer	0.000238	0.000357	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000236	0.000355	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—UGDH—liver cancer	0.000236	0.000353	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—SERPINE1—liver cancer	0.000235	0.000352	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TP53—liver cancer	0.000232	0.000347	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CSF2—liver cancer	0.000231	0.000347	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—RAF1—liver cancer	0.000231	0.000346	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CB—liver cancer	0.000228	0.000342	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF2—liver cancer	0.000228	0.000342	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—H2AFX—liver cancer	0.000228	0.000342	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—IL2—liver cancer	0.000228	0.000342	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CB—liver cancer	0.000225	0.000338	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—EPT1—liver cancer	0.000222	0.000332	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—HRAS—liver cancer	0.000222	0.000332	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PIK3CA—liver cancer	0.00022	0.00033	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.00022	0.00033	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TP53—liver cancer	0.000213	0.00032	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CSF2—liver cancer	0.000213	0.000319	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—RAF1—liver cancer	0.000212	0.000319	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TAT—liver cancer	0.00021	0.000315	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CG—liver cancer	0.00021	0.000315	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—H2AFX—liver cancer	0.00021	0.000315	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—IL2—liver cancer	0.00021	0.000315	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CB—liver cancer	0.000207	0.000311	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL2—liver cancer	0.000207	0.00031	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000207	0.00031	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TERT—liver cancer	0.000206	0.000309	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—HRAS—liver cancer	0.000204	0.000306	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARG—liver cancer	0.000203	0.000304	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—AKT1—liver cancer	0.000196	0.000293	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL2—liver cancer	0.000191	0.000286	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TERT—liver cancer	0.00019	0.000285	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KDR—liver cancer	0.000189	0.000283	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK14—liver cancer	0.000187	0.000281	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CD—liver cancer	0.000185	0.000277	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ESR1—liver cancer	0.000184	0.000276	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALB—liver cancer	0.000182	0.000273	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—F2—liver cancer	0.000182	0.000272	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—AKT1—liver cancer	0.00018	0.00027	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CG—liver cancer	0.000174	0.000261	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APC—liver cancer	0.000174	0.000261	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KDR—liver cancer	0.000174	0.00026	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK14—liver cancer	0.000172	0.000259	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ESR1—liver cancer	0.000169	0.000254	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—F2—liver cancer	0.000167	0.000251	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—BRAF—liver cancer	0.000163	0.000245	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CB—liver cancer	0.000161	0.000241	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APC—liver cancer	0.00016	0.00024	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CG—liver cancer	0.00016	0.00024	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000155	0.000232	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CD—liver cancer	0.000153	0.000229	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CA—liver cancer	0.000151	0.000227	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SERPINE1—liver cancer	0.000151	0.000227	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—BRAF—liver cancer	0.00015	0.000225	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—KRAS—liver cancer	0.00015	0.000224	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MYC—liver cancer	0.000149	0.000223	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GLUL—liver cancer	0.000143	0.000214	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CPT1B—liver cancer	0.000143	0.000214	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CD—liver cancer	0.000141	0.000211	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CA—liver cancer	0.000139	0.000209	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SERPINE1—liver cancer	0.000139	0.000208	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NR1H4—liver cancer	0.000138	0.000207	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—KRAS—liver cancer	0.000138	0.000206	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CA—liver cancer	0.000137	0.000206	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RAF1—liver cancer	0.000136	0.000204	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTA3—liver cancer	0.000135	0.000203	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MTOR—liver cancer	0.000133	0.0002	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CB—liver cancer	0.000133	0.0002	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—HRAS—liver cancer	0.000127	0.000191	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CA—liver cancer	0.000126	0.00019	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RAF1—liver cancer	0.000126	0.000188	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN1B—liver cancer	0.000125	0.000187	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTA4—liver cancer	0.000124	0.000186	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AKT1—liver cancer	0.000124	0.000185	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CB—liver cancer	0.000123	0.000184	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MTOR—liver cancer	0.000123	0.000184	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CASP3—liver cancer	0.000122	0.000184	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL2—liver cancer	0.000122	0.000183	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—liver cancer	0.000122	0.000182	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000121	0.000181	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTA2—liver cancer	0.000121	0.000181	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCND1—liver cancer	0.000119	0.000179	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JUN—liver cancer	0.000119	0.000178	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CTNNB1—liver cancer	0.000118	0.000177	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—HRAS—liver cancer	0.000117	0.000175	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTA1—liver cancer	0.000116	0.000175	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—liver cancer	0.000116	0.000174	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN1A—liver cancer	0.000115	0.000173	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NAT2—liver cancer	0.000115	0.000173	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN1B—liver cancer	0.000115	0.000172	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AKT1—liver cancer	0.000114	0.000171	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CASP3—liver cancer	0.000113	0.000169	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK8—liver cancer	0.000113	0.000169	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL2—liver cancer	0.000113	0.000169	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AKT1—liver cancer	0.000112	0.000168	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—liver cancer	0.000112	0.000168	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000111	0.000166	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALDOB—liver cancer	0.00011	0.000166	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCND1—liver cancer	0.00011	0.000164	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JUN—liver cancer	0.000109	0.000164	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CTNNB1—liver cancer	0.000109	0.000163	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—liver cancer	0.000107	0.00016	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN1A—liver cancer	0.000106	0.000159	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CRABP1—liver cancer	0.000105	0.000158	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—liver cancer	0.000104	0.000156	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK8—liver cancer	0.000104	0.000155	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AKT1—liver cancer	0.000103	0.000155	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—AKT1—liver cancer	0.000103	0.000155	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—STAT3—liver cancer	0.000103	0.000154	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CA—liver cancer	9.81e-05	0.000147	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—liver cancer	9.56e-05	0.000143	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MYC—liver cancer	9.56e-05	0.000143	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TGFB1—liver cancer	9.54e-05	0.000143	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.48e-05	0.000142	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—STAT3—liver cancer	9.47e-05	0.000142	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HPGDS—liver cancer	9.2e-05	0.000138	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.15e-05	0.000137	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KRAS—liver cancer	8.84e-05	0.000132	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MYC—liver cancer	8.8e-05	0.000132	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TGFB1—liver cancer	8.78e-05	0.000132	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.33e-05	0.000125	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.23e-05	0.000123	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PSMD10—liver cancer	8.2e-05	0.000123	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PSMA4—liver cancer	8.2e-05	0.000123	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KRAS—liver cancer	8.13e-05	0.000122	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CA—liver cancer	8.12e-05	0.000122	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AKT1—liver cancer	8.01e-05	0.00012	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GOT2—liver cancer	7.98e-05	0.00012	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—liver cancer	7.85e-05	0.000118	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HRAS—liver cancer	7.51e-05	0.000113	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP2E1—liver cancer	7.5e-05	0.000112	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CA—liver cancer	7.47e-05	0.000112	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.26e-05	0.000109	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—liver cancer	7.23e-05	0.000108	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—liver cancer	7.19e-05	0.000108	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYCS—liver cancer	7.02e-05	0.000105	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HRAS—liver cancer	6.91e-05	0.000104	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GGT1—liver cancer	6.89e-05	0.000103	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GOT1—liver cancer	6.89e-05	0.000103	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT1—liver cancer	6.63e-05	9.94e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—liver cancer	6.61e-05	9.92e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTP1—liver cancer	6.19e-05	9.28e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HMOX1—liver cancer	6.1e-05	9.15e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT1—liver cancer	6.1e-05	9.15e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTM1—liver cancer	5.69e-05	8.53e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP1A1—liver cancer	5.39e-05	8.08e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTHFR—liver cancer	5.03e-05	7.53e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARA—liver cancer	4.93e-05	7.39e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.43e-05	6.64e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CG—liver cancer	4.22e-05	6.33e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARG—liver cancer	4.08e-05	6.11e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CD—liver cancer	3.71e-05	5.57e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALB—liver cancer	3.66e-05	5.49e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CB—liver cancer	3.24e-05	4.85e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CA—liver cancer	1.97e-05	2.96e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKT1—liver cancer	1.61e-05	2.42e-05	CbGpPWpGaD
